Market Reports Assistance

  Vitrification Industry Overview The global vitrification market size was valued at USD 6.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 17.7% from 2021 to 2027. Expansions in fertility preservation techniques have prompted the development of vitrification. This new technique offers solutions for the preservation of specimens that not only reduce the preservation time but also minimizes the exposure to cryoprotectants. This has spurred the adoption of vitrification devices leading to lucrative revenue growth of the market. This area is considered a booming business in reproductive and women’s health domains and is expected to grow at a double-digit rate. Delayed childbearing due to sociodemographic factors, including education/career goals, the growing impact of women’s empowerment movements, financial barriers, and lack of a partner is one of the key driving factors of the market. This rising trend of delaying parenthood/childbearing has cr...

  Anti-biofilm Wound Dressing Industry Overview The global anti-biofilm wound dressing market size was valued at USD 606.57 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2021 to 2028. The worldwide increase in the incidence of chronic diseases, such as cancer and diabetes, is fueling the market growth. Factors such as unhealthy and sedentary lifestyles, antimicrobial resistance, alcohol consumption, and smoking are contributing to the growing prevalence of non-communicable diseases. As per the studies conducted by B. Braun Melsungen AG in 2018, around 2.0% to 10.0% of diabetic people suffer from diabetic foot ulcers. In addition, as per the American College of Physicians, in 2017, the global annual incidence rate of diabetic foot ulcers is around 6.3% and the lifetime incidence rate of foot ulcers in patients suffering from diabetes ranges from 19.0%-34.0%. Since anti-biofilm wound dressing products are highly recommended for treatin...

  Medical Supply Delivery Service Industry Overview The global medical supply delivery service market size was valued at USD 48.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.3% from 2021 to 2028. An increase in the volume of surgical procedures, coupled with the surge in the adoption of medical courier services for delivering medical supplies to healthcare facilities on time, is expected to fuel the market growth. The growing need to ensure quick and secure transportation of samples and specimens for testing, declining cost of logistics, and increasing focus on improving the healthcare system are driving the demand for medical supply delivery services. In addition, the increase in the incidence of road accidents that lead to blood loss and immediate requirement for blood is boosting the market growth. The expansion of healthcare logistics and rising demand for faster and cost-effective delivery of samples and specimens for testing or diagn...

  Fusion Biopsy Industry Overview The global fusion biopsy market size was valued at USD 489.1 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.6% from 2021 to 2028. Increasing prevalence of prostate cancer, growing awareness about the importance of regular clinical interventions, and developing reimbursement policies are factors likely to boost the demand for targeted MR/ultrasound biopsy systems over the forecast period. The global number of fusion biopsy procedures declined by around 50.0% during the first semester of the COVID-19 pandemic. Among the procedures that happened during this time, prostate MRI was preferred in most hospitals. The number of procedures, and thus, the demand for new devices resumed after July 2020 as the number of the cases stabilized at a global level. The low-risk patients were managed by an active surveillance strategy which helped minimize the hospital visits associated with COVID-19 risks. Availability of COVI...

  COVID-19 Clinical Trials Industry Overview The global COVID-19 clinical trials market size is valued at 5.0 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.5% from 2021 to 2027. The market is majorly driven by the rapid spread of coronavirus leading to a staggering number of deaths globally thus putting pressure on healthcare organizations to provide therapeutics/vaccines. The increasing research activities on a global scale are also creating demand for COVID-19 clinical trials, boosting the market growth. Factors such as globalization of clinical trials, demand for CROs to conduct clinical trials, and technological evolution, are further anticipated to drive growth. As per the World Health Organization (WHO), till June 24th, 2020, the virus had infected around 9.1 million people globally and had claimed more than 0.47 million lives with 80% cases in the U.S. and Europe overtaking China where the pandemic first began in December 2019. The U.S....

  Preparative And Process Chromatography Industry Overview The global preparative and process chromatography market size was valued at USD 7.15 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.65% from 2021 to 2028. Large-scale integration of liquid chromatographic techniques in downstream processing, technological advancements, and high demand for preparative techniques have accelerated the growth in this space. Increasing demand and approval of monoclonal antibodies in the pharmaceutical and biotechnology industries are expected to fuel the growth in this space throughout the forecast period. This can be attributed to the higher penetration of the service providers in the antibody separation techniques that are based on chromatographic principles, such as affinity chromatography and column displacement chromatography. Moreover, ongoing research paradigms for the separation and analysis of monoclonal antibodies using the mild reverse phase ch...

  COVID-19 Drug Delivery Devices Industry Overview The global COVID-19 drug delivery devices market size is valued at USD 1.87 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2022 to 2027. The drastic surge in drug development due to the COVID-19 outbreak and competitive race among the healthcare companies owing to the lack of effective treatments or vaccines are anticipated to create a lucrative environment for market growth. The unavailability of adequate medications and the absence of effective alternatives for COVID-19 management are anticipated to accelerate the U.S. FDA approval pathway, thus creating a surge for COVID-19 drug delivery devices by 2020 end. Drugmakers are in a rush to develop vaccines and therapies for the highly contagious coronavirus that has killed over 500,000 people worldwide, infected more than 10.5 million by the start of July 2020, and severely impacted the economies globally. The unprecedented outbreak has ...